AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FIREBRICK PHARMA LTD

0.063

0.000

Volume:- -

Turnover:- -

Market Cap:15.85M

PE:-5.03

High:0.063

Open:0.063

Low:0.063

Close:0.063

52wk High:0.100

52wk Low:0.050

Shares:251.57M

Float Shares:106.88M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.013

EPS(LYR):-0.013

ROE:-143.50%

ROA:-74.97%

PB:10.18

PE(LYR):-5.03

Loading ...

Overview Company News Filings

Firebrick Pharma Ltd-Firebrick Appoints New Independent Director

THOMSON REUTERS

Firebrick Pharma Ltd-Update on Registration of Nasodine in the Philippines

THOMSON REUTERS

BUZZ-Australia's Firebrick Pharma jumps on manufacturing new product for export

Firebrick Pharma Ltd-Firebrick Announces New Product Nasodine Throat Spray

THOMSON REUTERS

Firebrick Pharma Ltd-September 2025 Quarterly Activity Report & Appendix 4C

THOMSON REUTERS

Firebrick Pharma Secures Additional Investment of AU$102,000 From Philippines Strategic Partner

MT Newswires Live

Firebrick Pharma Ltd-Firebrick Secures Investment From Philippines Partner

THOMSON REUTERS

Firebrick Pharma Raises Over AU$1 Million via Placement

MT Newswires Live

BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius

BRIEF-Firebrick Pharma Secures A$1.4 Million From Investors

Firebrick Pharma - Secures a$1.4 Mln From Investors Issued at a$0.063 per Share

THOMSON REUTERS

Firebrick Pharma Ltd - License Agreement for Singapore, Malaysia, Brunei, Mauritius

THOMSON REUTERS

Firebrick Pharma Ltd - New Agreement Expected to Significantly Reduce Firebrick's Marketing Expenses in FY26

THOMSON REUTERS

BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Granted In Australia

Firebrick Pharma Ltd - Nasodine Covid-19 Patent Granted in Australia

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FRE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.063,"timestamp":1770959520000,"preClose":0.063,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"FIREBRICK PHARMA LTD","floatShares":106875635,"shares":251571369,"eps":-0.012528,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:12:00 AEDT","open":0.063,"high":0.063,"low":0.063,"amount":0,"amplitude":0,"askPrice":0.064,"askSize":100000,"bidPrice":0.063,"bidSize":506,"shortable":3,"etf":0,"ttmEps":-0.012528,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.063,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","floatShares":106875635,"roa":"-74.97%","roe":"-143.50%","lyrEps":-0.012528,"shares":251571369,"dividePrice":0,"high":0.063,"amplitude":0,"preClose":0.063,"low":0.063,"week52Low":0.05,"pbRate":"10.18","psRate":"30.74","week52High":0.1,"institutionHeld":0,"latestPrice":0.063,"committee":-0.989931,"eps":-0.012528,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.012528,"open":0.063,"prevYearClose":0.053,"prevWeekClose":0.068,"prevMonthClose":0.061,"prevQuarterClose":0.053,"fiveDayClose":0.068,"twentyDayClose":0.063,"sixtyDayClose":0.063},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610457666","title":"Firebrick Pharma Ltd-Firebrick Appoints New Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2610457666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610457666?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:19","pubTimestamp":1770671989,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUEBTJYXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2602568948","title":"Firebrick Pharma Ltd-Update on Registration of Nasodine in the Philippines","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568948","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568948?lang=en_us&edition=fundamental","pubTime":"2026-01-12 05:32","pubTimestamp":1768167168,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nTUE1MDT27:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2579258150","title":"BUZZ-Australia's Firebrick Pharma jumps on manufacturing new product for export","url":"https://stock-news.laohu8.com/highlight/detail?id=2579258150","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579258150?lang=en_us&edition=fundamental","pubTime":"2025-10-30 10:23","pubTimestamp":1761791000,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Firebrick Pharma jumps on manufacturing new product for export** Shares of Firebrick Pharma FRE.AX rise as much as 15.6% to A$0.074, their highest level since September 8** Stock logs biggest intraday pct rise since June 10** Pharmaceutical co commences manufacturing of Nasodine Throat Spray for export in November 2025** Stock is up 19.4% YTD, including the session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nL6N3WB05G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2579158467","title":"Firebrick Pharma Ltd-Firebrick Announces New Product Nasodine Throat Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2579158467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579158467?lang=en_us&edition=fundamental","pubTime":"2025-10-30 06:52","pubTimestamp":1761778357,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUEBTJ7WD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2577129123","title":"Firebrick Pharma Ltd-September 2025 Quarterly Activity Report & Appendix 4C","url":"https://stock-news.laohu8.com/highlight/detail?id=2577129123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577129123?lang=en_us&edition=fundamental","pubTime":"2025-10-23 05:23","pubTimestamp":1761168183,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nTUE5KZC9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2575798268","title":"Firebrick Pharma Secures Additional Investment of AU$102,000 From Philippines Strategic Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2575798268","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575798268?lang=en_us&edition=fundamental","pubTime":"2025-10-16 11:45","pubTimestamp":1760586318,"startTime":"0","endTime":"0","summary":"Firebrick Pharma (ASX:FRE) secured additional investment from its existing strategic investor, Pharma Nutria, of AU$102,000 via a placement of 1.2 million shares at a price of AU$0.085 apiece, accordi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2575501147","title":"Firebrick Pharma Ltd-Firebrick Secures Investment From Philippines Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2575501147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575501147?lang=en_us&edition=fundamental","pubTime":"2025-10-16 06:53","pubTimestamp":1760568835,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUE4DV0FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2562220358","title":"Firebrick Pharma Raises Over AU$1 Million via Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2562220358","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562220358?lang=en_us&edition=fundamental","pubTime":"2025-08-26 11:00","pubTimestamp":1756177220,"startTime":"0","endTime":"0","summary":"Firebrick Pharma (ASX:FRE) received firm commitments to raise AU$1.4 million through the issue of 22 million shares at AU$0.063 apiece, according to a Tuesday filing with the Australian bourse.Partici","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2562272296","title":"BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius","url":"https://stock-news.laohu8.com/highlight/detail?id=2562272296","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562272296?lang=en_us&edition=fundamental","pubTime":"2025-08-26 09:16","pubTimestamp":1756170979,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, MauritiusAug 26  - Firebrick Pharma Ltd FRE.AX:LICENSE AGREEMENT FOR SINGAPORE, MALAYSIA, BRUNEI, MAURITIUSNEW AGREEMENT EXPECTED TO SIGNIFICANTLY REDUCE FIREBRICK'S MARKETING EXPENSES IN FY26INNORINI APPOINTED EXCLUSIVE LICENSEE FOR NASODINE PRODUCTS IN SINGAPORE, MALAYSIA, BRUNEI AND MAURITIUSFurther company coverage: FRE.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UH0N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2562527254","title":"BRIEF-Firebrick Pharma Secures A$1.4 Million From Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2562527254","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562527254?lang=en_us&edition=fundamental","pubTime":"2025-08-26 09:04","pubTimestamp":1756170292,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Secures A$1.4 Million From InvestorsAug 26 (Reuters) - Firebrick Pharma Ltd FRE.AX:SECURES A$1.4 MILLION FROM INVESTORS ISSUED AT A$0.063 PER SHAREFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UH0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2562273068","title":"Firebrick Pharma - Secures a$1.4 Mln From Investors Issued at a$0.063 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2562273068","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562273068?lang=en_us&edition=fundamental","pubTime":"2025-08-26 06:10","pubTimestamp":1756159850,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2562717273","title":"Firebrick Pharma Ltd - License Agreement for Singapore, Malaysia, Brunei, Mauritius","url":"https://stock-news.laohu8.com/highlight/detail?id=2562717273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562717273?lang=en_us&edition=fundamental","pubTime":"2025-08-26 06:09","pubTimestamp":1756159771,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2562273748","title":"Firebrick Pharma Ltd - New Agreement Expected to Significantly Reduce Firebrick's Marketing Expenses in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2562273748","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562273748?lang=en_us&edition=fundamental","pubTime":"2025-08-26 06:09","pubTimestamp":1756159771,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0N6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2562295885","title":"BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Granted In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2562295885","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562295885?lang=en_us&edition=fundamental","pubTime":"2025-08-25 09:03","pubTimestamp":1756083831,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Granted In AustraliaAug 25 (Reuters) - Firebrick Pharma Ltd FRE.AX:NASODINE COVID-19 PATENT GRANTED IN AUSTRALIAFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UE0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2562267894","title":"Firebrick Pharma Ltd - Nasodine Covid-19 Patent Granted in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2562267894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562267894?lang=en_us&edition=fundamental","pubTime":"2025-08-25 06:14","pubTimestamp":1756073655,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250824:nFWN3UE0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}